Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2013; 19(47): 8887-8894
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.8887
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.8887
Risk factors | HBV-related HCC | HCV-related HCC |
Increased age | √[11-15] | √[16] |
Male gender | √[11,12,15] | √[16] |
Increased serum HBV DNA levels | √[11,12,14,15] | |
Presence of cirrhosis | √[12-14] | |
Increased serum ALT concentration | √[11,15] | |
HBeAg positivity | √[11,15] | |
Presence of core promoter mutations | √[12] | |
Presence of virological remission after 24 mo | √[13] | |
Presence of hypoalbuminemia | √[13] | |
Decreased serum albumin | √[14] | |
Increased serum bilirubin | √[14] | |
HBV genotype C | √[15] | |
Presence of HBsAg | √[15] | |
Family history of HCC | √[15] | |
Presence of portal hypertension | √[16] | |
Presence of hepatic inflammation | √[16] | |
Increased iron storage levels | √[16] | |
Presence of sustained virological response | √[17] | |
Presence of complete viral suppression | √[17] |
- Citation: Lu T, Seto WK, Zhu RX, Lai CL, Yuen MF. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. World J Gastroenterol 2013; 19(47): 8887-8894
- URL: https://www.wjgnet.com/1007-9327/full/v19/i47/8887.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i47.8887